Cell adhesion molecules and extracellular matrix proteins: Potential therapeutic applications

Expert Opinion on Investigational Drugs

Volumn 7, Issue 7, 1998, Pages 1159-1171

  Mousa, S A ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Cell adhesion molecules; Extracellular matrix proteins; Immunoglobulins; Integrins; Selectins; Therapeutics

Indexed keywords

ABCIXIMAB; AN 0026; ANTIBODY; CD31 ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPTIFIBATIDE; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; FRADAFIBAN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LAMIFIBAN; MONOCLONAL ANTIBODY; NEUTROPHIL INHIBITORY FACTOR; ORBOFIBAN; PADGEM PROTEIN; SCLEROPROTEIN; SIBRAFIBAN; TIROFIBAN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; XEMILOFIBAN;

DRUG DEVELOPMENT; DRUG TARGETING; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; RESTENOSIS; REVIEW; UNSTABLE ANGINA PECTORIS; WOUND HEALING;

EID: 0031903039     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.7.1159     Document Type: Review

References (81)